Biometric

1
Biometric Lab Screenings

• Debunking the myths to unlock the power of Total
  Population Health Management

2
Hooper Holmes Health Wellness

• New division of 109 year old health information
  company
• 9,000 examiners
• CLIA/CAP/NGSP certified laboratory
• FDA approved medical device manufacturer
• 50,000 sq foot warehouse and shipping facility
• Provide services exclusively to health care
  management companies
• Do not market to, or contract with, employers
• Private labeled screening solution (the Intel
  Inside)
• Screen groups and individuals in a variety of
  ways
• Screen both individuals and groups of all sizes
• Venipucture, Cholestech, self-collection kits
• 2008 accomplishments
• 200,000 health wellness screenings completed
• 4,000 screening events in over 1,700 cities in
  all fifty states, DC PR
• 99.6 participant satisfaction

3
Agenda

• I. Role of Screenings in Total Population
  Health Page 4
• Debunking Common Screening Myths Page 8
• III. Enabling Total Population Health
  Management Page 14

4
The move to total population health management
Well
At Risk
Ill
Chronically Ill
Acutely Ill
150 Million Covered Lives
20 of population
80 of population
5
Biometric lab data is a key enabler
Todays Cost
Tomorrows Cost
Well
At Risk
Ill
Chronically Ill
Acutely Ill
Claims Data
Biometric Lab Data
6
The importance of lab and biometric data

• Claims data is too late
• Participant is already ill
• Good for cost management, not cost avoidance
• Cant help reverse the trend
• HRA data alone is not enough
• 74 of respondents dont know their biometric or
  lab data
• Only reinforces what the participant knows
• Lab and biometric data fills in the gaps
• Data on those that you have no data on
• Objective data that uncovers unknown risks
• Provides a baseline and the data necessary to
  address the trend

7
Agenda

• I. Role of Screenings in Total Population
  Health Page 4
• Debunking Common Screening Myths Page 8
• III. Unlocking Total Population Health
  Management Page 14

8
SCREENING MYTH 1 Health fairs work

• Origins of the myth
• Consumers dont know whats possible or available
• Historical disconnect between health care mgmt.
• Historical lack of programs to act upon the data
• Screenings viewed only as an employee benefit
• Screenings viewed as a product
• Debunking the myth
• Stand alone health fairs cant pass the ROI test
• The real value of screenings is the data
  collected
• Ongoing engagement outperforms teachable moment
• Screenings are the front-end to other products

9
Screenings arent an event but the start of a
process
Debunking the myth
Uncover Risks
Stratify Pop
Target Programs
Biometric Screenings
Establish Baseline
Measure ROI
Engage Particip.
Motivate Change
10

• Origins of the myth
• DMAA study shows that providers see better
  incentives as having the greatest impact on
  program success
• Poor engagement strategies have been combated
  with higher incentives to increase participation
• Incentives viewed as a stand-alone program
  component
• Debunking the myth
• Employers see better identification of at-risk
  participants as having the greatest impact on
  program success
• All parties agree that engagement is key to
  success
• Incentives that are linked to coverage and
  program design can drive participation and
  engagement

11
HRA screening incentive
Debunking the myth
What to incent
HRA screening doing something about it
incentive
How to incent
Incentive cash or cash equivalent
Incentive plan feature generating cost shifting
Warning Incentive and program cannot become
adversarial to participants!
12
SCREENING MYTH 3Operational misunderstandings

• Operational Myths
• Fingerstick is cheaper than venipuncture with lab
  testing
• Screening stations are more efficient
• You cant efficiently reach remote individuals
• Debunking the myths
• A Cholestech cassette full lab panel both cost
  10
• Stations are championed by providers who dont
  have enough phlebotomists or Cholestech machines
• Individuals can be screened in home or office or
  with self-collection kits without breaking the
  bank

13
Agenda

• I. Role of Screenings in Total Population
  Health Page 4
• Debunking Common Screening Myths Page 8
• III. Unlocking Total Population Health
  Management Page 14

14
Redefining the role of biometric screenings

• Screenings are not
• A product
• An event
• Simply an employee benefit
• Screenings are
• A feeder for other products
• The beginning of an engagement process
• A powerful source of data

15
Integrating health care management

• Data integration
• Lab biometric data with claims pharmacy data
• Use screening data to establish a baseline to
  demonstrate future ROI of health management
• Product integration
• Screenings feed disease management
• Screenings as the front-end to intervention
  programs
• Incentive integration
• Incent action - not just participation
• Integrated incentive to shift costs

16
Role of screenings in total population health
Screening Data

Claims Rx Data
Participant Engagement

Stratified Population
Targeted Programs